AtriCure Q1 2024 Adj EPS $(0.25) Misses $(0.23) Estimate, Sales $108.851M Beat $106.902M Estimate
AtriCure Q1 2024 Adj EPS $(0.25) Misses $(0.23) Estimate, Sales $108.851M Beat $106.902M Estimate
AtriCure 2024 年第一季度經調整後每股收益 (0.25) 未達到預期 (0.23) 美元，銷售額爲1.088.51億美元，超過預期的1.069.02億美元
AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 8.7 percent decrease over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $108.851 million which beat the analyst consensus estimate of $106.902 million by 1.82 percent. This is a 16.43 percent increase over sales of $93.494 million the same period last year.
AtriCure（納斯達克股票代碼：ATRC）公佈的季度虧損爲每股0.25美元，比分析師普遍預期的0.23美元（0.23美元）低8.7％。這比去年同期每股虧損0.23美元（0.23）下降了8.7％。該公司公佈的季度銷售額爲1.08851億美元，比分析師普遍預期的1.06902億美元高出1.82％。這比去年同期的9,349.4萬美元的銷售額增長了16.43％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。